Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis
AUTOR(ES)
Xu, Xiao
FONTE
The National Academy of Sciences
RESUMO
Amyloid precursor proteins (APPs) are expressed in multiple organs and cell types in diverse species. Their conservation across species and high abundance in brain and the association of various APP missense mutations with autosomal dominant forms of familial Alzheimer’s disease (FAD) suggest important roles for APP in the central nervous system. However, the basic functions of APP in the central nervous system remain largely unknown. To assess potential effects of APP on neuronal death and survival, we transfected APP-deficient rat neuroblastoma cells (B103) with DNA constructs encoding wild-type or FAD-mutant human APP. Wild-type, but not FAD-mutant, APP effectively protected cells against apoptosis induced by ultraviolet irradiation, staurosporine, or p53. Wild-type APP also strongly inhibited p53 DNA-binding activity and p53-mediated gene transactivation, whereas FAD-mutant APP did not. We conclude that APP protects neuronal cells against apoptosis by controlling p53 activation at the post-translational level. Disruption of this function by mutations or alterations in APP processing could enhance neuronal vulnerability to secondary insults and contribute to neuronal degeneration.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22123Documentos Relacionados
- Two cellular proteins that bind to wild-type but not mutant p53.
- Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest.
- Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter.
- Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
- Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.